dr. llombart-cussac on eribulin in her2-negative metastatic breast cancer
Published 8 years ago • 271 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
2:11
dr. llombart-cussac on the cascade study in metastatic breast cancer
-
5:25
eribulin in metastatic breast cancer
-
3:40
treatment with eribulin in metastatic breast cancer
-
1:20
dr. o’shaughnessy on eribulin as first-line therapy for metastatic her2-negative breast cancer
-
6:51
treatment with eribulin mesylate in metastatic breast cancer
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
1:00
dr. mcintyre on eribulin as first-line therapy in her2- breast cancer
-
1:37
dr. chris twelves compares eribulin and capecitabine
-
2:19
dr. twelves discusses eribulin for the treatment of breast cancer
-
0:59
dr. linda vahdat on frontline eribulin plus trastuzumab in her2-positive mbc
-
2:08
dr. joyce o'shaughnessy on eribulin in metastatic breast cancer
-
2:42
eribulin as treatment for metastatic breast cancer
-
1:58
dr. alvarez on updated findings with eribulin in patients with her2 breast cancer
-
3:33
eribulin in metastatic tnbc: real-world data
-
9:49
patient selection for eribulin in breast cancer
-
3:00
eribulin’s role in triple-negative breast cancer
-
4:12
eribulin in recurrent metastatic er breast cancer
-
1:06
dr. tolaney on pembrolizumab plus eribulin in tnbc
-
1:23
dr. kaufman discusses the use of eribulin in metastatic breast cancer